tiprankstipranks
Trending News
More News >
Eterna Therapeutics (ERNA)
NASDAQ:ERNA
US Market

Eterna Therapeutics (ERNA) Income Statement

Compare
279 Followers

Eterna Therapeutics Income Statement

Last quarter (Q3 2025), Eterna Therapeutics's total revenue was $0.00, a decrease of -100.00% from the same quarter last year. In Q3, Eterna Therapeutics's net income was $-1.24M. See Eterna Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 582.00K$ 68.00K$ 0.00$ 0.00$ 0.00
Gross Profit
$ 486.00K$ -168.00K$ 0.00$ 0.00$ -98.00K
Operating Expenses
$ 16.16M$ 20.97M$ 33.22M$ 113.73M$ 7.15M
Depreciation and Amortization
$ 1.64M$ 1.12M$ 497.00K$ 459.00K$ 98.00K
EBITDA
$ -36.12M$ -19.93M$ -24.01M$ -121.95M$ -26.39M
Operating Income
$ -15.67M$ -21.14M$ -33.22M$ -113.73M$ -7.25M
Other Income/Expenses
$ -28.84M$ -536.00K$ 8.68M$ -8.75M$ -19.28M
Pretax Income
$ -44.51M$ -21.67M$ -24.53M$ -122.48M$ -26.53M
Net Income
$ -44.54M$ -21.67M$ -24.58M$ -122.55M$ 11.91M
Per Share Metrics
Basic EPS
$ -1.57$ -4.08$ -8.06$ -56.61$ -3.51
Diluted EPS
$ -1.57$ -4.08$ -8.06$ -56.61$ -3.51
Weighted Average Shares Outstanding
28.40M 5.31M 3.05M 2.17M 1.73M
Weighted Average Shares Outstanding (Diluted)
28.40M 5.31M 3.05M 2.17M 1.73M
Currency in USD

Eterna Therapeutics Earnings and Revenue History